Azar Tahghighi | Molecular Docking & Molecular Dynamic | Research Excellence Award

Published on by Network Science

Research Excellence Award

Azar Tahghighi
Pastur Institute of Iran
Azar Tahghighi
Affiliation Pastur Institute of Iran
Country Iran
Scopus ID 24923832500
Documents 47
Citations 728
h-index 15
Subject Area Molecular Docking & Molecular Dynamic
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0002-1221-4490

Azar Tahghighi is a researcher affiliated with the Pastur Institute of Iran whose scholarly activities span molecular docking, molecular dynamics simulations, medicinal chemistry, antimicrobial discovery, and computational drug design. Her body of work integrates in silico methodologies with experimental validation to investigate biologically active compounds, receptor-ligand interactions, and novel therapeutic candidates. Through contributions to peer-reviewed scientific literature, she has participated in advancing contemporary approaches for drug discovery and biological target identification.[1]

Abstract

This article summarizes the academic achievements and research contributions of Azar Tahghighi in the fields of medicinal chemistry and computational molecular sciences. Her research portfolio emphasizes molecular docking, molecular dynamics, pharmacophore modeling, antimicrobial agent discovery, and receptor-targeted therapeutic development. By combining computational prediction with laboratory validation, her work contributes to the identification of biologically relevant compounds and supports contemporary drug discovery strategies.[2]

Keywords

Molecular Docking, Molecular Dynamics, Medicinal Chemistry, Drug Discovery, TLR7 Ligands, Pharmacophore Modeling, Antibacterial Agents, Antibiofilm Activity, Computational Biology, Virtual Screening.

Introduction

Modern pharmaceutical research increasingly relies on computational techniques to accelerate therapeutic discovery and optimize candidate selection. Azar Tahghighi’s research aligns with this interdisciplinary trend by integrating computational chemistry, structural biology, and medicinal chemistry approaches. Her studies frequently investigate molecular interactions and biological pathways relevant to infectious diseases, immune modulation, and antimicrobial resistance.[3]

Research Profile

According to available scholarly metrics, the researcher has produced 47 indexed documents, accumulated 728 citations, and achieved an h-index of 15. Her scientific activities encompass molecular docking, molecular dynamic simulations, synthetic medicinal chemistry, receptor-targeted drug design, and antimicrobial evaluation. These contributions reflect sustained engagement with computational and experimental biomedical research.[1]

Research Contributions

  • Development of novel triazoloquinoxaline derivatives targeting Toll-like receptor 7.
  • Application of pharmacophore-based virtual screening and molecular docking techniques.
  • Investigation of antibacterial and antibiofilm compounds against resistant pathogens.
  • Research on probiotic-derived antibacterial extracts and microbial control strategies.
  • Evaluation of green chemistry approaches for antifungal drug synthesis.

Publications

  • Structure-guided design of triazolo[4,3-a] quinoxaline-4-ol derivatives as novel TLR7 ligands (2026).
  • Identification of new triazoloquinoxaline amine derivatives against Toll-like receptor 7 (2025).
  • Antibacterial and Antibiofilm Efficacy against MRSA (2025).
  • Click chemistry for green synthesis of antifungal medications (2024).
  • Anti-bacterial and anti-biofilm activity of probiotic Lactobacillus extracts (2024).

Research Impact

The research output demonstrates the practical application of computational methodologies for identifying promising therapeutic candidates. Publications addressing immune receptor modulation, antimicrobial resistance, and medicinal chemistry contribute to scientific understanding in areas of ongoing biomedical importance. Citation performance further indicates that her work has received recognition within relevant academic communities.[4]

Award Suitability

Azar Tahghighi’s multidisciplinary research profile demonstrates sustained scholarly productivity, measurable citation impact, and active engagement in computational and experimental biomedical sciences. Her contributions to molecular modeling, medicinal chemistry, and antimicrobial research align with the principles of research excellence recognized by international scientific award programs. The combination of publication quality, innovation, and translational relevance supports consideration for academic recognition.[5]

Conclusion

Azar Tahghighi has established a research portfolio focused on computational drug discovery, medicinal chemistry, and antimicrobial innovation. Through a combination of molecular modeling techniques and laboratory-based investigations, her work contributes to advancing therapeutic development and biological target evaluation. These accomplishments reflect a meaningful contribution to contemporary biomedical research and scientific scholarship.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Azar Tahghighi, Author ID 24923832500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24923832500
  2. Chemical Physics Impact. (2026). Structure-guided design of triazolo[4,3-a] quinoxaline-4-ol derivatives as novel TLR7 ligands.
    https://doi.org/10.1016/j.chphi.2026.101045
  3. PLOS One. (2025). Identification of new triazoloquinoxaline amine derivatives with potent modulatory effects against Toll-like receptor 7.
    https://doi.org/10.1371/journal.pone.0336701
  4. Journal of Medical Microbiology and Infectious Diseases. (2025). Antibacterial and Antibiofilm Efficacy of a Synthetic Nitrofuranyl Pyranopyrimidinone Derivative.
    https://doi.org/10.61882/JoMMID.13.2.139
  5. Chemical Biology & Drug Design. (2024). Click chemistry beyond metal-catalyzed cycloaddition as a tool for antifungal medication synthesis.
    https://doi.org/10.1111/cbdd.14555
  6. Iranian Biomedical Journal. (2024). Evaluation of Anti-Bacterial and Anti-Biofilm Activity of Native Probiotic Strains of Lactobacillus Extracts.
    https://doi.org/10.61186/ibj.4043

Anastasia Bougea | Biological Networks | Innovative Research Award

Published on by Network Science

Innovative Research Award

Anastasia Bougea
National and Kapodistrian University of Athens

Anastasia Bougea
Affiliation National and Kapodistrian University of Athens
Country Greece
Scopus ID 55629725400
Documents 136
Citations 2352
h-index 27
Subject Area Biological Networks
Event International Research Awards on Network Science & Graph Analytics
ORCID 0000-0003-3006-8711

Anastasia Bougea is a Greek researcher affiliated with the National and Kapodistrian University of Athens whose scholarly work spans neurology, neurodegenerative diseases, clinical neuroscience, digital health, and data-driven approaches to understanding complex biological systems. Her publication record demonstrates sustained contributions to Parkinson’s disease, dementia-related disorders, neuropsychological assessment, and emerging machine-learning methodologies in healthcare research.[1] Through interdisciplinary investigations integrating clinical evidence, neurological biomarkers, and computational analysis, her research aligns with contemporary developments in biological network science and translational medicine.[2]

Abstract

This article summarizes the academic profile of Anastasia Bougea and evaluates her suitability for recognition through the Innovative Research Award. Her body of work reflects a multidisciplinary approach linking neurological disorders, clinical diagnostics, machine learning, mobile health technologies, and molecular mechanisms of neurodegeneration. The scope and continuity of her contributions indicate an active engagement with contemporary biomedical challenges and network-oriented approaches to disease understanding.[3]

Keywords

Biological Networks, Neurodegenerative Diseases, Parkinson’s Disease, Machine Learning, Clinical Neuroscience, Mobile Health, Dementia, Alpha-Synuclein, Biomarkers, Graph Analytics.

Introduction

Research into neurodegenerative diseases increasingly relies on interconnected biological data, computational modeling, and predictive analytics. Anastasia Bougea’s scholarly activities contribute to this evolving landscape through studies addressing disease mechanisms, clinical assessment tools, and technology-assisted healthcare solutions. Her work demonstrates the integration of biomedical knowledge with analytical methods relevant to modern network science applications.[4]

Research Profile

With 136 indexed publications, 2,352 citations, and an h-index of 27, Bougea has established a substantial academic presence. Her research portfolio encompasses Parkinson’s disease, dementia with Lewy bodies, frontotemporal dementia, non-coding RNA therapeutics, and digital health technologies. Her publication activity reflects sustained engagement with peer-reviewed international journals and collaborative research initiatives.[1]

Research Contributions

  • Applied machine learning techniques for predicting multiple system atrophy and progressive supranuclear palsy.
  • Investigated therapeutic opportunities involving non-coding RNAs in neurodegenerative diseases.
  • Reviewed molecular pathways associated with alpha-synuclein and GBA1-related neurological disorders.
  • Explored mobile health technologies supporting Parkinson’s disease management.

Publications

  • Machine learning-based prediction of multiple system atrophy and progressive supranuclear palsy using clinical and neuropsychological scores (2026).
  • Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases (2026).
  • Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review (2026).
  • Underlying Mechanisms of GBA1 in Parkinson’s Disease and Dementia with Lewy Bodies (2025).
  • Mobile Health Technologies for the Management of Parkinson’s Disease (2025).

Research Impact

The impact of Bougea’s research is reflected through citation activity, interdisciplinary relevance, and practical implications for neurological healthcare. Her studies support improved understanding of disease progression, digital monitoring technologies, and predictive clinical tools. These contributions help bridge translational research with patient-centered applications and data-driven decision-making frameworks.[5]

Award Suitability

Anastasia Bougea demonstrates characteristics commonly associated with innovative research recognition, including interdisciplinary scholarship, measurable scientific impact, and continued publication productivity. Her integration of machine learning, molecular neuroscience, and mobile health technologies contributes to emerging approaches within biological networks and graph-informed biomedical analysis. These achievements provide a strong basis for consideration within the International Research Awards on Network Science & Graph Analytics.[6]

Conclusion

Bougea’s academic record reflects sustained contributions to neuroscience and neurodegenerative disease research. Her work combines clinical relevance with analytical innovation, supporting advancements in predictive medicine and network-based biomedical understanding. The breadth of her scholarly output and demonstrated impact support recognition within an international research award framework.

References

  1. Elsevier. (n.d.). Scopus author details: Anastasia Bougea, Author ID 55629725400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55629725400
  2. Bougea, A. (2026). Machine learning-based prediction of multiple system atrophy and progressive supranuclear palsy using clinical and neuropsychological scores.
    DOI: https://doi.org/10.1016/j.bnd.2026.02.002
  3. Bougea, A. (2026). Targeting Non-Coding RNAs as a Potential Therapeutic and Delivery Strategy Against Neurodegenerative Diseases.
    DOI: https://doi.org/10.3390/ijms27073260
  4. Bougea, A. (2026). Role of Alpha-Synuclein in Frontotemporal Dementia: Narrative Review.
    DOI: https://doi.org/10.3390/cells15050470
  5. Bougea, A. (2025). Underlying Mechanisms of GBA1 in Parkinson’s Disease and Dementia with Lewy Bodies.
    DOI: https://doi.org/10.3390/genes16121496
  6. Bougea, A. (2025). Mobile Health Technologies for the Management of Parkinson’s Disease.
    DOI: https://doi.org/10.1080/14737175.2025.2580468

Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Nikhil Sudhir Sathe | Biological Networks | Best Researcher Award

Reliance Life Sciences Pvt Ltd | India

Dr. Nikhil Sudhir Sathe (PhD), currently associated with Laboratory Animal Research Services (LARS), is a distinguished researcher with over 20 years of expertise in drug discovery and preclinical evaluation of new chemical entities. His extensive professional experience encompasses in vitro genotoxicology, cell and microbial culture (aerobic, anaerobic, and viral systems including rabies virus), and small laboratory animal studies. Throughout his career at Reliance Life Sciences, Vimta Labs, Dabur Research Centre, and Wockhardt Research Centre, Dr. Sathe has demonstrated exceptional proficiency in GLP-compliant laboratory practices, including bacterial reverse mutation, chromosomal aberration, micronucleus, ELISA, cytotoxicity, and microbial monitoring assays. His early research contributions involved innovative in vitro models for evaluating the efficacy of antimicrobial and cosmetic products. Academically, he holds a Master’s and Bachelor’s degree in Microbiology from Shivaji University, Kolhapur, both with distinction. Dr. Sathe has contributed significantly to scientific literature with publications in reputed journals such as Vaccine, Microbial Pathogenesis, Infectious Medicine, and BioMed, focusing on bacteriophage therapy and vaccine development against multidrug-resistant pathogens and SARS-CoV-2. His scholarly achievements are complemented by active participation in national conferences and workshops, reflecting his deep commitment to advancing microbiological and biomedical research.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Unveiling Lytic Bacteriophages as Promising Biotherapeutics for the Control of Multidrug-Resistant Pseudomonas aeruginosa", CS Nikhil Sathe, Eugene Athan, Arnab Kapat, BioMed, 2025.

"Safety, immunogenicity and efficacy of Relcovax®, a dual receptor binding domain (RBD) and nucleocapsid (N) subunit protein vaccine candidate against SARS-CoV-2 virus", N Sathe, S Shaikh, M Bhavsar, L Parte, A Gadiparthi, S Kad, S Sensarma, Vaccine, 2024.

"Bacteriophage vB_kpnS-Kpn15: Unveiling its potential triumph against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae-Unraveling efficacy through innovative", N Sathe, C Suphioglu, E Athan, A Kapat, Microbial Pathogenesis, 2024.

"Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatment", N Sathe, P Beech, L Croft, C Suphioglu, A Kapat, E Athan, Infectious medicine 2, 2023.

"Development of a novel therapy using bacteriophages: An alternative to antibiotics", NS Sathe, Deakin University, 2023.

Raquel Martín García | Biological Network | Best Research Article Award

Published on by Network Science

Dr. Raquel Martín García | Biological Network | Best Research Article Award

Puerta de Hierro University Hospital Majadahonda | Spain

Dr. Raquel Martín García is a highly accomplished neurologist specializing in movement and sleep disorders, with extensive academic and clinical expertise. She earned her Degree in Medicine and Surgery (2010–2016) and is currently pursuing her Doctorate in Medicine and Surgery at the Autonomous University of Madrid. After completing her Neurology specialization at Puerta de Hierro University Hospital (2017–2021), she has since served as a Specialist Physician in the Movement Disorders Unit and the Sleep Unit at leading hospitals and research centers in Madrid, including the Sleep Research Institute and CISNe Comprehensive Sleep and Neuroscience Center. Dr. Martín García holds multiple postgraduate qualifications, including a Master’s in Movement Disorders, expert titles in Headaches and Neurosonology, and advanced certifications in cerebrovascular and hereditary neurological diseases. Her research contributions include several publications in prestigious international journals such as European Journal of Neurology, Brain Sciences, and Epilepsy & Behavior, as well as book chapters for Springer and the Oxford Handbook of Sleep and Sleep Disorders. She has actively presented her work at major neurology conferences, participated as a sub-investigator in numerous Phase II and III clinical trials on Parkinson’s disease and multiple sclerosis, and contributed to teaching and mentoring at the Autonomous University of Madrid. Recognized for her dedication to advancing neurological sciences, she received the STADA Fellowship from the AMN Movement Disorders Group in 2024.

Profiles: Scopus

Featured Publications

"Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study", Martín García R, Plos One, 2025.

Thiru Nirai Senthil | Computer Science | Best Academic Researcher Award

Published on by Network Science

Dr. S. Thiru Nirai Senthil | Computer Science | Best Academic Researcher Award

Jawahar Science College | India

Author Profile

Google Scholar

Early Academic Pursuits

Dr. S. Thiru Nirai Senthil began his academic journey with a strong foundation in computer science and engineering, developing expertise that would later encompass diverse domains such as bioinformatics, artificial intelligence, network security, and data mining. His early exposure to both computational technologies and biological systems enabled him to adopt an interdisciplinary approach to research. Over the years, he built a rich portfolio of technical skills, contributing to areas from molecular modeling and protein analysis to large-scale network optimization and machine learning applications.

Professional Endeavors

With an extensive career in academia, Dr. Senthil has served in pivotal roles, including Head of the Department of Computer Science and Engineering at PRIST University, overseeing curriculum design, departmental administration, and faculty development. His professional experience extends to acting as Chief Superintendent and Additional Chief Superintendent for examination processes, member of various academic boards, and leader in event organization. He has consistently bridged the gap between theoretical research and practical application, guiding students, designing academic programs, and managing university-level technological systems such as ERP CAMU for admissions and data management.

Contributions and Research Focus

Dr. Senthil’s research spans multiple high-impact areas, notably artificial intelligence, machine learning, data mining, cloud computing, IoT, wireless sensor networks, bioinformatics, and cybersecurity. His contributions include the development of algorithms for optimized clustering, secure cloud storage auditing, intelligent e-learning systems, and AI-driven healthcare solutions. His interdisciplinary publications address both technological and societal challenges, such as AI-assisted medical devices, data-driven pandemic analysis, and sentiment analysis for social media monitoring. He has presented papers at prestigious national and international conferences, including ICICACS, ASCIS, ICRTSM, and the Asian Mycological Congress, demonstrating global engagement in research dissemination.

Impact and Influence

Dr. Senthil’s work has had a significant influence on both academic and applied technology communities. His AI-based patents in healthcare, autonomous navigation, and social media analytics showcase his commitment to impactful innovation. He has authored books on core computing subjects-Artificial Intelligence, Machine Learning, Data Mining and Warehousing, and Client-Server Computing-providing valuable academic resources for students and professionals alike. His leadership in faculty development programs, organization of technical workshops, and delivery of expert lectures has shaped the learning environment for countless students and educators.

Academic Citations and Recognition

His research publications have been widely cited, particularly in areas involving AI for agriculture, healthcare, and network optimization. Recognition of his scholarly contributions includes prestigious honors such as the Researcher Excellence Award (2025) and the Global Eminent Academician Award (2021), acknowledging both his research impact and his dedication to teaching excellence.

Legacy and Future Contributions

Dr. Senthil’s academic legacy lies in his ability to integrate multidisciplinary domains, creating solutions that address real-world problems while advancing theoretical frameworks. His role as a research guide and doctoral committee member ensures the training of future scholars, while his patents lay the groundwork for continued innovation. Moving forward, his work is poised to expand into emerging areas of generative AI, advanced machine learning models, and AI-driven biomedical devices, promising further contributions to science, technology, and society.

Conclusion

Dr. S. Thiru Nirai Senthil exemplifies the modern academician—innovative, interdisciplinary, and dedicated to the advancement of knowledge. His career reflects a rare combination of research excellence, pedagogical commitment, and visionary leadership. With an impressive record of publications, patents, and academic service, he continues to influence the trajectory of research in computer science and its allied fields, leaving a lasting mark on both academia and industry.

Notable Publications

"LCNFN: LeNet‐Cascade Neuro‐Fuzzy Network for Grape Leaf Disease Segmentation and Multi‐Classification" 

  • Author: G Selvaraj, SV Puthenkaleelkal, P Alaguchamy, STN Senthil
  • Journal: Journal of Phytopathology
  • Year: 2025

"COVID-19 Adaptive E-Learning: Data-Driven Student Engagement Analysis" 

  • Author: LL Rani, ST Senthil
  • Journal: International Conference on Integrated Circuits
  • Year: 2024

"Text Classification with Automatic Detection of COVID-19 Symptoms from Twitter Posts Using Natural Language Programming (NLP)" 

  • Author: N Manikandan, S Thirunirai Senthil
  • Journal: International Conference on Advancements in Smart Computing
  • Year: 2023

"Efficient College Students Higher Education Prediction Using Machine Learning Approaches" 

  • Author: L Lalli Rani, S Thirunirai Senthil
  • Journal: International Conference on Advancements in Smart Computing
  • Year: 2023

"Improved Genetic Algorithm Based k-means Cluster for Optimized Clustering" 

  • Author: FM Ilyas, ST Senthil
  • Journal: International Conference on Advancements in Smart Computing
  • Year: 2023

 

Fatemeh Safari | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Fatemeh Safari | Biological Networks | Best Researcher Award

Assistant Professor at Shiraz University of Medical Sciences, Iran📖

Dr. Fatemeh Safari is an Assistant Professor at the Diagnostic Laboratory Science and Technology Research Center, Shiraz University of Medical Sciences, Iran. She holds a PhD in Medical Biotechnology from Tabriz University of Medical Sciences, where she also completed her MSc in the same field. Her academic journey began with a BSc in Nursing from Shiraz University of Medical Sciences. With expertise in genome editing, cell culture, and protein biochemistry, Dr. Safari has contributed significantly to the field of biotechnology, specializing in gene expression regulation and improving recombinant CHO cell productivity.

Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

Education Background🎓

  • PhD in Medical Biotechnology
    Tabriz University of Medical Sciences, Tabriz, Iran (2015-2021)
  • MSc in Medical Biotechnology
    Tabriz University of Medical Sciences, Tabriz, Iran (2010-2013)
    Top student in the program, elected student by the organization for Gifted and Talented Education
  • BSc in Nursing
    Shiraz University of Medical Sciences, Shiraz, Iran (2001-2004)
    Elected student by the organization for Gifted and Talented Education

Professional Experience🌱

  • Assistant Professor, Diagnostic Laboratory Science and Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (2024–Present)
    In charge of the cell culture room, designing and implementing research projects, and mentoring MSc and Ph.D. students.
  • Senior Researcher, Diagnostic Laboratory Science and Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (2020–2023)
    Led research in genome editing, cell culture, and protein biochemistry techniques.
  • Laboratory Assistant, R&D Applied Drug Research Center, Tabriz University of Medical Sciences, Tabriz, Iran (2013–2014)
    Gained hands-on experience in animal studies, cell culture, and immunization techniques.
  • Emergency Medical Technician, EMS and Disaster Management Center, Shiraz, Fars, Iran (2005–2013)
    Trained in resuscitation and participated in disaster and emergency medical events.
Research Interests🔬

Dr. Safari’s research primarily focuses on genome editing using the CRISPR/Cas9 system, regulation of gene expression, and the enhancement of CHO cell productivity. She is also dedicated to advancing protein expression and purification techniques, particularly in the fields of molecular cloning and cell-based assays. Furthermore, Dr. Safari investigates small animal models and stem cell culture for therapeutic applications.

Author Metrics

Dr. Safari has contributed to multiple research projects and publications in the field of medical biotechnology. Her work in CRISPR gene editing and cell culture technologies has been widely recognized, and she actively participates in academic workshops on molecular biology and biotechnology techniques. Her teaching experience includes mentoring graduate and Ph.D. students, and she is an expert in advanced laboratory techniques and molecular cellular biology.

Publications Top Notes 📄

1. CRISPR Cpf1 Proteins: Structure, Function, and Implications for Genome Editing

  • Authors: F. Safari, K. Zare, M. Negahdaripour, M. Barekati-Mowahed, Y. Ghasemi
  • Journal: Cell & Bioscience
  • Volume: 9
  • Pages: 1-21
  • Year: 2019
  • Citations: 198
  • Summary: This paper explores the CRISPR/Cpf1 system, a novel genome-editing tool, and its applications in genetic engineering. It provides an in-depth look at the structure and functions of the Cpf1 protein and its potential advantages over other CRISPR systems like Cas9.

2. Overview of Albumin and Its Purification Methods

  • Authors: R. Raoufinia, A. Mota, N. Keyhanvar, F. Safari, S. Shamekhi, J. Abdolalizadeh
  • Journal: Advanced Pharmaceutical Bulletin
  • Volume: 6
  • Issue: 4
  • Pages: 495
  • Year: 2016
  • Citations: 165
  • Summary: This review covers the properties of albumin, a critical protein in pharmaceutical and medical applications, and discusses various techniques for its purification, emphasizing its importance in therapeutic use.

3. Immunotoxins in Cancer Therapy: Review and Update

  • Authors: B. Akbari, S. Farajnia, S. Ahdi Khosroshahi, F. Safari, M. Yousefi, …
  • Journal: International Reviews of Immunology
  • Volume: 36
  • Issue: 4
  • Pages: 207-219
  • Year: 2017
  • Citations: 149
  • Summary: This paper provides an overview of immunotoxins and their evolving role in cancer immunotherapy. It reviews the latest developments in immunotoxin-based treatments, which combine targeted antibody therapy with toxic agents to destroy cancer cells.

4. CRISPR System: A High-Throughput Toolbox for Research and Treatment of Parkinson’s Disease

  • Authors: F. Safari, G. Hatam, A.B. Behbahani, V. Rezaei, M. Barekati-Mowahed, …
  • Journal: Cellular and Molecular Neurobiology
  • Volume: 40
  • Pages: 477-493
  • Year: 2020
  • Citations: 65
  • Summary: This article reviews the use of the CRISPR/Cas9 gene-editing system in the context of Parkinson’s disease research and therapy. It highlights high-throughput methods for studying the disease and potential CRISPR-based treatments.

5. CRISPR and Personalized Treg Therapy: New Insights into the Treatment of Rheumatoid Arthritis

  • Authors: F. Safari, S. Farajnia, M. Arya, H. Zarredar, A. Nasrolahi
  • Journal: Immunopharmacology and Immunotoxicology
  • Volume: 40
  • Issue: 3
  • Pages: 201-211
  • Year: 2018
  • Citations: 65
  • Summary: This review discusses the role of regulatory T cells (Tregs) in the immune system and how CRISPR-based technologies can be used for personalized therapies to treat autoimmune diseases, particularly rheumatoid arthritis.

Conclusion

Dr. Fatemeh Safari is a highly deserving candidate for the Best Researcher Award, given her groundbreaking contributions to medical biotechnology, particularly in genome editing, cell culture, and protein biochemistry. Her research in CRISPR/Cas9 technology, its applications in disease treatment, and her dedication to teaching and mentoring future scientists are noteworthy. While there are opportunities for her to expand the practical applications and international reach of her work, her academic and research achievements already place her at the forefront of her field. The recognition through the Best Researcher Award would not only honor her past achievements but also serve as a platform for the next stage of her career, allowing her to make even greater strides in biotechnology and medical research.